Lonza Sets Mid-Term Targets, Confirms 2026 Outlook
Lonza set new mid-term targets and confirmed its 2026 outlook ahead of its capital markets day. It said third-quarter performance was in line with expectations across its business areas.
Lonza is seeking to become a pure-play drug manufacture…